Quarterly report pursuant to Section 13 or 15(d)

Interim Statements of Operations and Comprehensive loss

v2.4.0.6
Interim Statements of Operations and Comprehensive loss (USD $)
3 Months Ended 84 Months Ended
Feb. 29, 2012
Feb. 28, 2011
Feb. 29, 2012
EXPENSES:      
Research and Product Development cost (recovery) $ (215,143) $ 159,809 $ 7,473,781
Amortization 2,284 2,696 42,643
General and administration 421,189 166,872 10,170,430
TOTAL OPERATING EXPENSES 208,330 329,377 17,686,854
LOSS FROM OPERATIONS (208,330) (329,377) (17,686,854)
Other expense-Interest (44,101) 0 (114,379)
Other Income-Interest 0 0 272,594
LOSS BEFORE INCOME TAXES (252,431) (329,377) (17,528,639)
Income taxes 0 0 0
NET LOSS AND COMPREHENSIVE LOSS $ (252,431) $ (329,377) $ (17,528,639)
Loss per share - basic and diluted $ (0.01) $ (0.01)   
Weighted average common shares outstanding 26,828,050 25,878,050